The purpose of the DISCOVER study is to pilot acceptable approaches to people with covert cerebrovascular disease (CCD) and their follow-up. This is the first step in designing efficient randomised trials of treatments to reduce the risk of stroke or dementia in people with CCD.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Functional scores
Timeframe: At 3, 6 and 12 months following enrolment
Cognitive scores
Timeframe: At 3, 6 and 12 months following enrolment
Speech samples
Timeframe: At 3, 6 and 12 months following enrolment
Vascular events
Timeframe: At 3, 6 and 12 months following enrolment